Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × SCLC × 90 days × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 462 Neoplasms 420 Carcinoma, Non-Small-Cell Lung 332 Prostatic Neoplasms 296 Lung Neoplasms 243 Colorectal Neoplasms 226 Neoplasm Metastasis 188 Ovarian Neoplasms 167 Leukemia, Myeloid, Acute 164 Multiple Myeloma 158 Pancreatic Neoplasms 154 Stomach Neoplasms 124 Endometrial Neoplasms 120 Recurrence 117 Melanoma 116 Squamous Cell Carcinoma of Head and Neck 109 Uterine Cervical Neoplasms 102 Triple Negative Breast Neoplasms 102 Brain Neoplasms 101 Carcinoma, Hepatocellular 100 Precursor Cell Lymphoblastic Leukemia-Lymphoma 99 Urinary Bladder Neoplasms 95 Lymphoma 93 Glioblastoma 90 Head and Neck Neoplasms 85 Carcinoma, Renal Cell 82 Sarcoma 81 Hematologic Neoplasms 79 Lymphoma, Non-Hodgkin 74 Esophageal Neoplasms 74

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07110103 2026-02-27

JACKPOT38

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡